Brief: Hainan Runming Biotechnology Co Reports 23.25% Stake In Aesthetic Medical International Holdings Group As Of May 30, 2022
10/06/2022 11:40
June 10 (Reuters) - Aesthetic Medical International Holdings
Group Ltd AIH.O :
* HAINAN RUNMING BIOTECHNOLOGY CO REPORTS 23.25% STAKE IN
AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP AS OF MAY 30,
2022
Further company coverage: AIH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aesthetic Medical International Holdings
See all newsBrief: Aesthetic Medical Announces Receipt Of Decision From Nasdaq Hearings Panel For Conditional Continued Listing
Brief: Aesthetic Medical International Announces Receipt Of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Brief: Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results
Brief: Aesthetic Medical International Holdings Group Ltd Received A Letter Of Expected Delisting Determination From Nasdaq Staff And Requested A Hearing Before The Nasdaq Hearings Panel
Brief: Aesthetic Medical International And Investors Entered Into A Share Purchase Agreement, A Subscription Agreement, A Shareholders’ Agreement And A Cooperation Agreement